Microarray-Based CD38 Peptide Probe Screening for Multiple Myeloma Imaging.

Li, Xuejie; Wang, Yuanzhuo; Yang, Qi; Song, Lele; Kang, Lei; Hu, Zhiyuan; Wang, Zihua

Li, Xuejie; Wang, Yuanzhuo; Yang, Qi; Song, Lele; Kang, Lei; Hu, Zhiyuan; Wang, Zihua.

Affiliation

Li X; Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Wang Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
Yang Q; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
Song L; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Kang L; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Hu Z; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
Wang Z; Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.

Mol Pharm ; 21(1): 245-254, 2024 Jan 01.

Article in En | MEDLINE | ID: mdl-38096423

Subject(s)

Multiple Myeloma; Mice; Animals; Multiple Myeloma/diagnostic imaging; Cell Line, Tumor; Positron-Emission Tomography/methods; Peptides/chemistry; Multimodal Imaging/methods; Gallium Radioisotopes/chemistry

Key words

CD38; in vivo imaging; microchip-based screening; multiple myeloma (MM); targeting peptide

Fulltext

XML

PubMed Links

Search on Google